This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ZIKAVAC (Inactivated Virus)

Bharat Biotech

Drug Names(s): Zika Vaccine, ZIKAVAC

Description: Bharat Biotech is developing ZIKAVAC, a Zika vaccine, using inactivated virus.

ZIKAVAC (Inactivated Virus) News

Scrip Oncorus Raises $79.5m To Take Its First Oncolytic Virus Into The Clinic

Scrip Transgene Downplays Impact Of Pexa-Vec Phase III Cancer Trial Failure

Pink Sheet Is Another Heparin Crisis Looming? Congress Raises Alarm, Demands US FDA Briefing

Pink Sheet US FDA Gives RMAT Boost To AlloVir As Viralym-M Phase III Planning Continues

Additional information available to subscribers only:

Targets
Routes
Catalysts
Designations
Events

Request a Free Demo Subscriber Login Search for another drug